Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101-Reference-Cited by-同舟云学术

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101

Published:2022-10 Issue:5 Volume:7 Page:100564
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Tomita Y.,Larkin J.,Venugopal B.,Haanen J.,Kanayama H.,Eto M.,Grimm M.-O.,Fujii Y.,Umeyama Y.,Huang B.,Mariani M.,di Pietro A.,Choueiri T.K.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Systemic therapy for metastatic renal-cell carcinoma;Choueiri;N Engl J Med,2017

2. Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma;Bukowski;Front Oncol,2012

3. Immune checkpoint inhibitors in renal cell carcinoma;Ross;Clin Sci,2017

4. Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma;Carlo;Nat Rev Urol,2016

5. Antibody-dependent cellular cytotoxicity activity of a novel anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells;Boyerinas;Cancer Immunol Res,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral blood cytokines and outcomes with immune checkpoint blockade: a systematic review and meta-analysis;Immunotherapy;2024-08-19

2. Avelumab first‐line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3 trial;Cancer Medicine;2024-06

3. Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses from the JAVELIN Renal 101 trial;BMJ Oncology;2024-06

4. Rapidly progressing sarcomatoid cell renal cell carcinoma in a hemodialysis patient： A case report;Nihon Toseki Igakkai Zasshi;2024

5. Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma;Cancer Discovery;2023-12-21